home  versant ventures search for versant ventures on linkedin share lp access contact us careers ive built two companies with versant ventures and value their distinctive investment approach they have a clear understanding of the recipe for startup company success and represent a premium brand in healthcare venture capital today david clapper  minerva surgical versant invested in life the people at versant understand the entrepreneurial process they take a longterm view of the portfolio company and help provide perspective and support in times thick and thin amar sawhney  ocular therapeutix versant invested in life versant has been and continues to be a superb investor they provide insight and counsel to our efforts and their willingness to roll up their sleeves to problem solve with us has been invaluable michael d clayman md  flexion therapeutics versant invested in life featured case study biotechnology quanticel pharmaceuticals quanticel technology is based on the work of stanford researchers and company founders stephen quake and michael clarke versant had backed other genomic technologies invented by quake and moved quickly to incubate quanticel in  shortly after the company was founded the idea behind quanticel’s singlecell genomic analysis technology is to unlock the mystery of cancer drug resistance through the analysis of tumor cell heterogeneity as a tumor grows and cancer cells rapidly replicate the genetic diversity of these cells increases full quanticel pharmaceuticals case study news highlights venatorx pharmaceuticals raises  million series b venatorxfinal repare therapeutics raises us million series a repare therapeutics raises us million series a crispr therapeutics announces the appointment of jon terrett phd to head of immunooncology research and translation crispr appoints jon terrett versant ventures launches jecure therapeutics jecureseriesa contact us  versant ventures search for versant ventures on linkedin share lp access contact us careers contact us at one of our five offices san francisco one sansome suite  san francisco ca  phone   fax   new york  west st street suite  new york ny  phone   minneapolis  equitable drive suite  eden prairie mn  phone   basel switzerland versant ventures switzerland gmbh aeschenvorstadt  ch basel switzerland phone      canada versant ventures canada limited  great northern way suite 0 vancouver bc vt t phone   versant overview  versant ventures search for versant ventures on linkedin share lp access contact us careers propelling life sciences companies versant ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies the firm invests across the healthcare sector and at all stages of company development with an emphasis on the discovery and development of novel therapeutics with  billion under management and offices in north america and europe versant has built a team with deep investment operating and scientific expertise that enables a handson approach to company building since the firm’s founding in  nearly 0 versant companies have achieved successful acquisitions or ipos versant in europe versant ventures has a team in basel switzerland dedicated to working with entrepreneurs industry and leading academics across europe the team has decades of experience in the pharmaceutical and biotechnology industries including global roles in drug discovery research and product development for companies such as roche novartis and lilly versant’s basel office is led by tom woiwode guido magni and gianni gromo   biotechnology archives  versant ventures search for versant ventures on linkedin share lp access contact us careers biotechnology venatorx pharmaceuticals malvern pa venatorx is a developing nextgeneration antibiotics to treat multidrug resistant mdr infections vividion therapeutics san diego ca vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteomewide drug and target discovery repare therapeutics montreal canada repare is developing new precision oncology drugs for patients that target specific vulnerabilities of tumor cells northern biologics toronto canada northern biologics is developing novel therapeutic antibodies for the treatment of human diseases in oncology fibrosis and other diseases piqur therapeutics basel switzerland piqur is a swiss pharmaceutical company focusing on the discovery and development of innovative small molecule therapeutics based on lipid kinase pik and mtor inhibition for the treatment of cancer as well as other indications anokion ecublens switzerland anokion is focused on leveraging its proprietary immune tolerance technology to develop novel protein therapeutics and treatments for autoimmune diseases mosaic biomedicals barcelona spain mosaic biomedicals is a barcelonabased company that develops personalized cancer treatments with a dual mechanism of action to eliminate cancer stem cells and reactivate the tumor’s immune system mosaic’s innovative treatments are derived from a deep understanding of the tumor biology and aim to offer safer and more effective options to cancer patients aavlife paris france aavlife is a gene therapy company focused on developing treatments for rare diseases with great unmet medical need inception ibd san diego ca inception ibd is focused on translating academic discoveries in the field of ibd into firstinclass small molecule drugs crispr therapeutics basel switzerland crispr therapeutics is making use of significant advances in the field of gene editing and focused on translating the crisprcas technology in truly transformational therapeutics for common and rare genetic diseases audentes therapeutics san francisco ca audentes is a biotechnology company committed to the development and commercialization of innovative new treatments for people with serious rare diseases through the application of gene therapy technology gensight biologics tassin la demi lune  france gensight is a leading company in gene therapy specialized in prevention of loss of vision and restoration of sight inception  san diego ca inception  is focused on the discovery of therapeutics for sensorineural hearing loss  the company has entered into a partnership with roche with a prenegotiated acquisition at ind viral logic systems technology seattle wa vlst corp has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases theraclone sciences seattle wa theraclone sciences inc is focused on developing novel human therapeutic antibodies for the treatment of infectious diseases acumen san francisco ca acumen is revolutionizing the diagnosis and treatment of autism and other disorders through smartphoneenabled digital behavior evaluation improving outcomes for patients and simplifying care for specialists phaserx seattle wa phaserx is developing a novel approach to intracellular delivery of macromolecules inception  san diego ca inception  is focused on oncology the company is translating biological insights into novel firstinclass small molecule drugs for cll and other oncology indications spanning both liquid and solid tumors inception  san diego ca inception  is translating biological insights into novel firstinclass small molecule drugs to treat diseases of aging ruiyi shanghai china ruiyi is a drug discovery and development company focused on firstinclass antibodies targeting g protein coupled receptors gpcrs am ventures menlo park ca am ventures is a seedstage fund focused on creating and building biotech companies portfolio companiesbiotechnology biotechnology exits  ipos medical devices medical device exits  ipos additional investments additional investment exits discovery engines case studies amira pharmaceuticals inception  inc quanticel pharmaceuticals medical devices archives  versant ventures search for versant ventures on linkedin share lp access contact us careers medical devices ebb therapeutics oakmont pa ebb is developing a therapeutic device for insomnia inari medical irvine ca inari medical is a medical device company pioneering innovative devices for the interventional treatment of vascular thrombi and emboli metavention minneapolis mn metavention is developing novel interventional therapies for type  diabetes sebacia duluth ga sebacia is developing a medical device to cure acne zyga technology minneapolis mn zyga is developing and marketing innovative minimally invasive surgical solutions to treat conditions of the spine rox medical san clemente ca rox is developing devices for treatment of diseases of the respiratory system respicardia minnetonka mn respicardia is developing an implantable system to treat central sleep apnea in patients with heart failure orametrix richardson tx orametrix is a leading industry provider of innovative d technology solutions facilitating and improving the quality of orthodontic care neurotech pharmaceuticals lincoln ri neurotech pharmaceuticals is pioneering encapsulated cell technology as a drug delivery platform for retinal degenerative diseases minerva surgical cupertino ca minerva is developing next–generation technology for treating excessive menstrual bleeding microfabrica van nuys ca microfabrica has developed a broad microscale platform for minimally invasive procedures and for complex dynamic implants intuity medical sunnyvale ca intuity medical formerly rosedale is developing a handheld all inone discrete bloodbased diagnostic platform that will enhance glucose monitoring for diabetic patients holaira plymouth mn novel devices to treat obstructive lung disease  previously innovative pulmonary solutions halscion suwanee ga halscion is advancing a solution for reduction of surgically induced scarring forsight vision  menlo park ca forsight vision is evaluating a variety of technologies to address important unmet patient needs in key ophthalmic markets forsight vision  menlo park ca forsight vision  inc is developing novel ocular drug delivery technologies ceterix orthopedics fka suturepro technologies inc menlo park ca ceterix is developing a new orthopedic suturing technology that is focused on improving easeofuse and operative speed celula san diego ca celula is developing rare cell isolation technology for diagnostic and therapeutic purposes benvenue medical santa clara ca benvenue medical is developing and marketing innovative spine repair technology alterg fremont ca alterg is marketing its “gtrainer” technology a treadmill system that reduces the users’ body weightimpact of running and thereby enhances physical rehabilitation from orthopedic or neurological injury acufocus irvine ca acufocus is developing a corneal implant to treat presbyopia the need for reading glasses portfolio companiesbiotechnology biotechnology exits  ipos medical devices medical device exits  ipos additional investments additional investment exits discovery engines case studies amira pharmaceuticals inception  inc quanticel pharmaceuticals portfolio overview  versant ventures search for versant ventures on linkedin share lp access contact us careers partnering to improve healthcare we are proud of our track record of working with extraordinary scientists entrepreneurs and business leaders to build transformational companies that impact and improve healthcare we invest our time talent leadership and expertise in all our portfolio partnerships we pursue opportunities where we can add value through our handson collaborative approach and devote the appropriate mix of strategic advice domain expertise and capital to help accelerate their growth we invest in life and in success since our inception in  we have invested in over  seed early and growth stage companies – of which  have gone public or been acquired to date contact us  versant ventures search for versant ventures on linkedin share lp access contact us careers contact us at one of our five offices san francisco one sansome suite  san francisco ca  phone   fax   new york  west st street suite  new york ny  phone   minneapolis  equitable drive suite  eden prairie mn  phone   basel switzerland versant ventures switzerland gmbh aeschenvorstadt  ch basel switzerland phone      canada versant ventures canada limited  great northern way suite 0 vancouver bc vt t phone   bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright  007 · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version versant venture capital v canada lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors versant venture capital v canada lp check out list of companies and businesses related to versant venture capital v canada lp find out versant venture capital v canada lp address and contact details view other people related to versant venture capital v canada lp  coworkers colleagues companions etc address one sansome street suite  san francisco  ca companies related to versant venture capital v canada lp cikcompany namepositioncompany address7crispr therapeutics agbaarerstrasse  zug ch versant venture capital v canada lp on the web persons related to versant venture capital v canada lp  crispr therapeutics agnamepositioncitybehbahani alibaselaktiengesellschaft bayer leverkusenglobal investments bv bayer rt mijdrechtmarc beckerali behbahanidirector timoniumbradley j phd bolzondirector menlo parkbolzon bradleybaselpablo j cagnonidirector denvercelgene corp de0 owner summitn anthony colesdirector cambridgetyler dylanhydechief legal officer cambridgekurt von emsterdirector bostonsimeon georgedirector conshohockenplc glaxosmithkline0 owner brentford middlesexhadley harbor master investors cayman lp0 owner bostonsubramanian kalacambridgejames r kasingercambridgesamarth kulkarniplease see remarks cambridgevon emster kurtbaselsven ante lundbergchief scientific officer cambridgebecker marccambridgecoles nbaselrodger novakchief executive officer cambridgecagnoni pablobaselnovak rodgerbaselkulkarni samarthcambridgegeorge simeonbaselkala subramaniansee remarks cambridgelundberg svencambridgewoiwode thomasbaseldylanhyde tylercambridgeversant affiliates fund v lpsan franciscoversant ophthalmic affiliates i lpsan franciscoversant side fund iv lpmenlo parkversant venture capital iv lp0 owner menlo parkversant venture capital v lpsan franciscothomas woiwodedirector menlo park versant venture capital v canada lp  list of ceos founders and company directors directorpedianet  list of ceos founders board members and company directors versant venture capital v canada lp list of persons related to the company versant venture capital v canada lp find out list of ceos founders board members and company directors of versant venture capital v canada lp cik number 0company address 0 sand hill road suite 0 menlo park 0phone number  people related to versant venture capital v canada lp namepositionstreetcitycountrybolzon bradley0 sand hill road suite 0 menlo parkcanielsen kirk0 sand hill road suite 0 menlo parkcal praeger robin0 sand hill road suite 0 menlo parkcajaffe ross0 sand hill road suite 0 menlo parkcacolella samuel0 sand hill road suite 0 menlo parkcawoiwode tom0 sand hill road suite 0 menlo parkcana versant ventures v llc0 sand hill road suite 0 menlo parkcalink william0 sand hill road suite 0 menlo parkca versant venture capital v canada lp on the web related companiesversant affiliates fund ia lp versant affiliates fund ib lp versant affiliates fund v lp versant holdings inc versant ophthalmic affiliates i lp versant side fund i lp versant side fund ii lp versant venture capital v lp versant venture capital vi canada lp versant venture capital vi lp versant venture v aiv feeder holdings lp versant venture v aiv lp versant venture capital v canada lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active versant venture capital v canada lp • san francisco ca • venture capital fund how do i update this listing versant venture capital v canada is based out of san francisco the firm last filed a form d notice of exempt offering of securities on 00 the filing was for a pooled investment fund venture capital fund the notice included securities offered of pooled investment fund interests summary dg insider form  form d  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from versant venture capital v canada lp enter your email address below and choose submit your email cancel contact info versant venture capital v canada lp one sansome street san francisco ca     business phone  recent sec filings a filed on   filed on 0  filed on 0 da filed on 00 schedule d and g events since 007 subscription required form   nonderivative insider transactions since 007 loading form d filings form d is a form to be used to file a notice of an exempt offering of securities with the securities and exchange commission form d contains basic information about the offering and the company form d filings filing date form type industry group securities offered total offering amount total amount sold total remaining 00 da pooled investment fund venture capital fund pooled investment fund interests 00   other issuers in filings name address versant affiliates fund v lp 0 sand hill road building  suite 0 menlo park ca 0 versant ophthalmic affiliates i lp 0 sand hill road building  suite 0 menlo park ca 0 versant venture capital v lp 0 sand hill road building  suite 0 menlo park ca 0 related parties included in filings name address relationship bradley bolzon subscription required director kirk nielsen subscription required director na versant ventures v llc subscription required director robin l praeger subscription required director ross jaffe subscription required director samuel colella subscription required director tom woiwode subscription required director william link subscription required director elevate your investments try it for free ﻿ company profile add company sign in with sign in with add company add event sign in with sign in with android iphone companies events company events message this company message the business message this company message the business post your social media updates network would you like businessvibes to send this message to similar companies in this industry profile visits prev visits  total  current  share and improve this company’s performance boost this company’s visibility by sharing it with your contacts about company financial details x receive updates from textiles companies in india for free receive updates from textiles companies in india for free   already a businessvibes member login what kind of updates will i receive latest business listings as they become available current trends that are making noise in your industry reports and articles about your market pushed directly to you you will also receive early access to the businessvibes mobile app access to full profiles can help you instantly contact businesses directly pursue and qualify leads for your business research and find business offerings that you seek you will also receive early access to the businessvibes mobile app x were glad that youre back simply login and unlock full profile easy one click login dont worry we never post without your permission         or         already an active user login with your email   forgot password new to businessvibes sign up x receive updates from textiles companies in india for free already in businessvibes login access to open trade requests can help you find products and services early less competition for trade requests more costeffective than traditional trade requests microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext7 about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext707 where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within 0 days ext707 personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext707 personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext707 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows 0 click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext70 legal privacy  cookies  07 microsoft microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext7 about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext707 where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within 0 days ext707 personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext707 personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext707 personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows 0 click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext70 legal privacy  cookies  07 microsoft bayer to invest up to  mln in versant ventures newest fund  pe hub subscribe to pe hub wire join over 0 of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital bayer to invest up to  mln in versant ventures’ newest fund november  0 by iris dorbian print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub bayer to invest up to  mln in versant ventures newest fund versant ventures latest fund has added bayer healthcare as an lp bayer will invest up to  million in versant venture capital v the fund will back the development of new therapies in areas of high unmet medical need in addition to investing in the fund bayer will join its advisory board continue reading on pe hub writes versant ventures‘ latest fund has added bayer healthcare as an lp bayer will invest up to  million in versant venture capital v the fund will back the development of new therapies “in areas of high unmet medical need” in addition to investing in the fund bayer will join its advisory board press release bayer healthcare will invest up to usd  million as a strategic investor in versant ventures’ newly formed “versant venture capital v” fund to support the development of new therapies in areas of high unmet medical need versant ventures is a global healthcare venture capital firm investing in biotech and medical device companies throughout the us europe and canada bayer along with other limited partners of the fund will be a member of the advisory board to versant’s “venture capital v” fund contributing its longstanding expertise in drug discovery and development versant’s fund management team maintains full decision making rights as to investments in portfolio companies “versant ventures has an excellent track record promoting entrepreneurship in life sciences and healthcare driven by a team of experts with a global reach” said prof dr andreas busch member of the bayer healthcare executive committee and head of global drug discovery “bayer’s mission is science for a better life our commitment parallels versant’s vision to advance early medical innovation and patient care we are looking forward to supporting promising early stage companies that are addressing disease areas of high unmet medical need” “we are excited about bayer’s support for our latest fund and look forward to sharing our expertise in drug discovery and development” said brad bolzon managing director at versant ventures “we share similar goals of stimulating and promoting innovation in healthcare to eventually affect patient outcome” bayer and versant ventures have already joined forces in ophthalmology research in november 0 bayer healthcare announced an exclusive collaboration with inception sciences – a drug discovery incubator exclusively backed by versant ventures – to conduct early research in the area of retinal eye diseases for this purpose versant ventures established “inception ” – a company with the aim to develop innovative treatment options for patients suffering from eye diseases such as wet agerelated macular degeneration and geographic atrophy bayer holds an exclusive option to acquire “inception ” under certain undisclosed conditions about versant ventures versant ventures is a leading venture capital firm that specializes in investments in game changing biopharmaceuticals medical devices and other life science opportunities founded in  the firm consists of an experienced team of managing directors committed to helping entrepreneurs build successful companies that impact healthcare and improve quality of life about bayer healthcare the bayer group is a global enterprise with core competencies in the fields of health care agriculture and hightech materials bayer healthcare a subgroup of bayer ag with annual sales of eur  billion 0 is one of the world’s leading innovative companies in the healthcare and medical products industry and is based in leverkusen germany bayer healthcare combines the global activities of the animal health consumer care medical care and pharmaceuticals divisions bayer healthcare’s aim is to discover develop manufacture and market products that will improve human and animal health worldwide bayer healthcare has a global workforce of 0 employees dec  0 and is represented in more than  countries more information is available at wwwhealthcarebayercom print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub bayer to invest up to  mln in versant ventures newest fund versant ventures latest fund has added bayer healthcare as an lp bayer will invest up to  million in versant venture capital v the fund will back the development of new therapies in areas of high unmet medical need in addition to investing in the fund bayer will join its advisory board continue reading on pe hub writes dont miss out meet new and diverse managers in private equity venture capital and real estate at the third emerging manager connect east at new york citys harvard club click here for details sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts kkr to buy nature’s bounty from carlyle by luisa beltran blackrock leads funding round for fintech platform icapital by iris dorbian platinum equity to buy united site services by luisa beltran the pe hub podcast episode two by staff report private equity jobs of the week priceline kpmg novaquest are hiring by eamon murphy raymond james expands team with new hire by iris dorbian the carveout curveball by pehublogger network private equity jobs of the week cambridge associates bank of america ubs are hiring by eamon murphy versant ventures closes new 0 mln fund with help of canadian lps  pe hub subscribe to pe hub wire join over 0 of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital versant ventures closes new 0 mln fund with help of canadian lps december 0 0 print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub versant ventures closes new 0 mln fund with help of canadian lps us venture capital firm versant ventures has closed versant venture capital v lp at us0 million surpassing its initial target of us0 million the fund will invest across the global healthcare sector and at all stages of company development versant which has an office in vancouver has received capital commitments for fund v from a number of canadian institutional investors including bdc capital fonds de solidarité ftq northleaf venture catalyst fund and teralys capital this support owed to versant’s current and planned activity in developing canada’s life sciences ecosystem continue reading on pe hub writes us venture capital firm versant ventures has closed versant venture capital v lp at us0 million surpassing its initial target of us0 million the fund will invest across the global healthcare sector and at all stages of company development versant which has an office in vancouver has received capital commitments for fund v from a number of canadian institutional investors including bdc capital fonds de solidarité ftq northleaf venture catalyst fund and teralys capital this support owed to versant’s current and planned activity in developing canada’s life sciences ecosystem press release versant ventures closes 0 million healthcare fund san francisco–business wire–versant ventures a global healthcare investment firm today announced the close of versant venture capital v lp at 0 million and in excess of the initial fund target of 0 million since its inception versant has raised  billion to invest in innovative biopharmaceutical medical device and healthcare serviceshcit companies the firm invests from offices in north america and europe and it has assembled a team with deep investment operating and scientific expertise that enables a handson approach to company building “it’s an exciting time to be launching versant v and we look forward to working with talented teams coinvestors and industry partners to advance important therapies and technologies that have the potential to substantially impact the industry” the versant v portfolio will be diversified with investments made across the healthcare sector and at all stages of company development consistent with recent strategy a primary focus will be the discovery and development of novel therapeutics many of these companies will be launched by versant and will enter into “buildtobuy” structured acquisitions with strategic partners at the outset key to that strategy are the firm’s company creation engines inception sciences and blueline bioscience which in recent years have collectively spawned seven companies and executed almost as many strategic partnerships the remainder of the fund will be devoted to high potential companies in other healthcare sectors that are in need of growth capital to develop or commercialize their products investments out of versant v began earlier this year and a number of commitments have already been made including to northern biologics a company launched by blueline bioscience that will develop novel therapeutic antibodies in a strategic partnership with celgene “we are grateful for the support of our limited partners who allow us to pursue our mission of helping exceptional entrepreneurs build the next generation of great healthcare companies” said brad bolzon managing director “it’s an exciting time to be launching versant v and we look forward to working with talented teams coinvestors and industry partners to advance important therapies and technologies that have the potential to substantially impact the industry” about versant ventures versant ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies the firm invests across the healthcare sector and at all stages of company development with an emphasis on the discovery and development of novel therapeutics with  billion under management and offices in north america and europe versant has built a team with deep investment operating and scientific expertise that enables a handson approach to company building since the firm’s founding in  nearly 0 versant companies have achieved successful acquisitions or ipos for more information please visit wwwversantventurescom contacts versant ventures luciana castro 00 email protected photo courtesy of shutterstock print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub versant ventures closes new 0 mln fund with help of canadian lps us venture capital firm versant ventures has closed versant venture capital v lp at us0 million surpassing its initial target of us0 million the fund will invest across the global healthcare sector and at all stages of company development versant which has an office in vancouver has received capital commitments for fund v from a number of canadian institutional investors including bdc capital fonds de solidarité ftq northleaf venture catalyst fund and teralys capital this support owed to versant’s current and planned activity in developing canada’s life sciences ecosystem continue reading on pe hub writes dont miss out meet new and diverse managers in private equity venture capital and real estate at the third emerging manager connect east at new york citys harvard club click here for details sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts clairvest to sell crs to ashtead’s sunbelt rentals for 7 mln by kirk falconer novacap’s fifth techbuyout fund blows by target raises 0 mln by kirk falconer five questions with john ruffolo ceo of omers ventures by kirk falconer birch hill to buy ccm hockey brand from adidas for 0 mln by kirk falconer mitel tries again to buy shoretel in 0 mln deal by kirk falconer fintech platform borrowell raises  mln in vc  mln in debt by kirk falconer omers to earn x its money with 7 bln sale of civica by kirk falconer brookfield to acquire  pct of teekay offshore for 70 mln by kirk falconer